Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (1141-1150 of 1,218) with videos related to

Pageof 122
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2025
The novel lysophosphatidic acid receptor 1-selective antagonist, ACT-1016-0707, has unique binding properties that translate into effective antifibrotic and anti-inflammatory activity in different models of pulmonary fibrosisMagdalena Birker-Robaczewska, Maxime Boucher, Giulia Ranieri, et al.
Leukemia|November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotypeA Clipson, M Wang, L de Leval, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for experimental models of myocardial ischemia and infarctionMerry L Lindsey, Roberto Bolli, John M Canty, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Blood|March 20, 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changesMarta Lionetti, Margherita Scopetti, Antonio Matera, et al.
Blood Advances|June 3, 2024
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysisFrancesca Lazzaroni, Antonio Matera, Alessio Marella, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
Acta Oncologica (Stockholm, Sweden)|March 18, 2021
Nestin and CD34 expression in colorectal cancer predicts improved overall survivalAthanasios Tampakis, Benjamin Weixler, Silvan Rast, et al.
Transplantation and Cellular Therapy|June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple MyelomaSarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Blood Advances|November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter studyBruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Pageof 122

Showing results (1141-1150 of 1,218) with videos related to

Sort By:
Pageof 122
The Journal of Pharmacology and Experimental Therapeutics|March 12, 2025
The novel lysophosphatidic acid receptor 1-selective antagonist, ACT-1016-0707, has unique binding properties that translate into effective antifibrotic and anti-inflammatory activity in different models of pulmonary fibrosisMagdalena Birker-Robaczewska, Maxime Boucher, Giulia Ranieri, et al.
Leukemia|November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotypeA Clipson, M Wang, L de Leval, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for experimental models of myocardial ischemia and infarctionMerry L Lindsey, Roberto Bolli, John M Canty, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Blood|March 20, 2025
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changesMarta Lionetti, Margherita Scopetti, Antonio Matera, et al.
Blood Advances|June 3, 2024
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysisFrancesca Lazzaroni, Antonio Matera, Alessio Marella, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
Acta Oncologica (Stockholm, Sweden)|March 18, 2021
Nestin and CD34 expression in colorectal cancer predicts improved overall survivalAthanasios Tampakis, Benjamin Weixler, Silvan Rast, et al.
Transplantation and Cellular Therapy|June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple MyelomaSarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Blood Advances|November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter studyBruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Pageof 122